Guidance on imports of faulty condoms, medical gloves
This article was originally published in The Gray Sheet
Executive Summary
FDA releases two final guidance documents July 11 outlining a risk-based strategy for dealing with manufacturers' imports of 1condoms and of 2medical gloves that repeatedly do not meet FDA's quality criteria. CDRH says some foreign manufacturers and shippers attempt to import condoms and medical gloves that fail water leak testing, putting users at risk. The agency will place manufacturers of faulty condoms or medical gloves into a two-year, three-tiered import surveillance and detention cycle. If the firm reaches final Level 3 detention within the 24 months, FDA may refuse import. The documents finalize 2000 draft guidance
You may also be interested in...
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
P&G Restores Volume Growth In Beauty, Grooming After Pricing Run
Procter & Gamble reports strong consumer spending in the US and Europe after a 3% increase in product pricing over the past year. Dragging on fiscal third-quarter results, sales of SK-II in China fell 30% for the January-March period, while lower incidence of cough and cold impacted Health Care performance.
BMS Has A Strong Pipeline, But Access Challenges Remain
Bristol Myers Squibb’s head of major markets, Monica Shaw, wants to improve patients’ access to lifesaving therapies. And the group has several new products ready to roll.